Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pirus Ghadjar

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
BJU International|October 31, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPirus Ghadjar, George N Thalmann
Lancet (London, England)|May 2, 2021
Postoperative radiotherapy in prostate cancerPirus Ghadjar, Stefan Höcht, Thomas Wiegel
European Urology|May 20, 2017
Re: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate CancerMarcus Beck, Stefanie Hayoz, Pirus Ghadjar
Cancer|February 3, 2011
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancerAxel Madlung, Mathew Simcock, Pirus Ghadjar
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 29, 2021
Non-thermal membrane effects of electromagnetic fields and therapeutic applications in oncologyPeter Wust, Ulrike Stein, Pirus Ghadjar
Cancers|May 28, 2022
Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and InnovationStephan Bodis, Pirus Ghadjar, Gerard van Rhoon
European Urology|September 12, 2017
Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7Alan Dal Pra, Stephane Supiot, Pirus Ghadjar
Journal of the National Cancer Institute|March 4, 2014
RE: Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancerPirus Ghadjar, Volker Budach, Daniel R Zwahlen
Current Urology Reports|March 17, 2015
Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancerGiovannalberto Pini, Justin Collins, Pirus Ghadjar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2020
In Regard to Wang et alPirus Ghadjar, Marcus Beck, Sebastian Zschaeck, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
BJU International|October 31, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPirus Ghadjar, George N Thalmann
Lancet (London, England)|May 2, 2021
Postoperative radiotherapy in prostate cancerPirus Ghadjar, Stefan Höcht, Thomas Wiegel
European Urology|May 20, 2017
Re: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate CancerMarcus Beck, Stefanie Hayoz, Pirus Ghadjar
Cancer|February 3, 2011
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancerAxel Madlung, Mathew Simcock, Pirus Ghadjar
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 29, 2021
Non-thermal membrane effects of electromagnetic fields and therapeutic applications in oncologyPeter Wust, Ulrike Stein, Pirus Ghadjar
Cancers|May 28, 2022
Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and InnovationStephan Bodis, Pirus Ghadjar, Gerard van Rhoon
European Urology|September 12, 2017
Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7Alan Dal Pra, Stephane Supiot, Pirus Ghadjar
Journal of the National Cancer Institute|March 4, 2014
RE: Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancerPirus Ghadjar, Volker Budach, Daniel R Zwahlen
Current Urology Reports|March 17, 2015
Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancerGiovannalberto Pini, Justin Collins, Pirus Ghadjar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2020
In Regard to Wang et alPirus Ghadjar, Marcus Beck, Sebastian Zschaeck, et al.
Pageof 19